At the end of March, DNA-Technology took a part in the international symposium "News in microbiological diagnosis and therapy of infections – The future is now" in Serbia.
+7 495 640-17-71
info@dna-technology.com
ENG
RUS
X
Menu
At the end of March, DNA-Technology took a part in the international symposium "News in microbiological diagnosis and therapy of infections – The future is now" in Serbia.
We glad to present a new booklet on the test Androflor®, which clearly and concisely formed answers to questions such as - why to choice this test, indications for use, particularities of biomaterial collection and the obtained results interpretation.
It's a new complex analysis to quantify the gut microbiota composition of 0-14 years old children. The technology based on real-time PCR, one of the most accurate and fastest method, which allows to detect 99,9% of microorganism species of children's gut microbiota.
From 6 to 8 October 2026, DNA-Technology participated in the international healthcare exhibition WHX Johannesburg 2026.
DNA-Technology is pleased to invite you to visit us at Booth H3.L31 at WHX Johannesburg 2026, taking place on October 6–8, 2026, in Johannesburg, South Africa.
DNA-Technology is taking part in the first INNOPROM exhibition in India
DNA-Technology, hosted a delegation of representatives from government and scientific institutions of the Republic of India.
From July 8–10, DNA-Technology successfully completed its participation in WHX Bangkok 2026 — the largest industry forum in Southeast Asia.
Medicine is one of the most precise sciences dealing with the most imprecise subject: the human being.
May 20–22, 2026 – The 31st Kazakhstan International Healthcare Exhibition KIHE 2026 took place in Almaty. It is the largest platform in Central Asia for showcasing achievements in scientific and practical medicine.
DNA‑Technology and the ITGEL Erüül Mend Clinic (Ulaanbaatar) have been working together for over a decade, advancing modern molecular diagnostics technologies in Mongolia.
This is perhaps one of the most widely discussed and debated questions in reproductive medicine. Seeking to move closer to an answer based on the results of their own research, physicians from leading Austrian clinics specializing in assisted reproductive technologies (ART), together with specialists from DNA-Technology, undertook a dedicated study. Follicular fluid samples from 24 women undergoing IVF/ICSI procedures were selected for analysis, and the microbial spectrum was assessed using the FEMOFLOR®16 and ANDROFLOR®. It was found that the absence of bacterial DNA correlates with a high probability of successful fertilization. The key role in predicting ART outcomes appears to belong to the overall microbial impact leading to disruption of the dynamic balance of the microbiota.